Common Contracts
3 similar Registration Rights Agreement contracts by Opexa Therapeutics, Inc., Pure Bioscience, Inc., Repros Therapeutics Inc.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • October 28th, 2015 • Pure Bioscience, Inc. • Miscellaneous chemical products • New York
Transactions with Management. In the table on the following page, describe any transaction (or series of similar transactions), during the Company’s last three Fiscal Years, or any currently proposed transaction (or series of similar transactions), to which the Company or any of its subsidiaries was or is to be a party, and in which you had or anyone in your immediate family has, a material direct or indirect financial interest. Identify the person (s) involved and state the nature of your or their interest in the transaction, the amount of the transaction and the amount of your or their interest in the transaction . (Attach a supplemental page if necessary.)
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 12th, 2012 • Repros Therapeutics Inc. • Biological products, (no disgnostic substances) • Texas
This REGISTRATION RIGHTS AGREEMENT (the “Agreement’) is made effective as of August 31, 2012, by and among Repros Therapeutics Inc., a Delaware corporation (the “Company”), and each of the persons executing a copy of this Agreement (each an “Investor” and, collectively, the “Investors”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 26th, 2012 • Opexa Therapeutics, Inc. • Pharmaceutical preparations • Texas
This REGISTRATION RIGHTS AGREEMENT (the “Agreement”) is made effective as of July 25, 2012, by and among Opexa Therapeutics, Inc., a Texas corporation (the “Company”), and each of the persons executing a copy of this Agreement (each an “Investor” and, collectively, the “Investors”).
